FREAMINE III 8.5% W/ ELECTROLYTES
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE
Approval overview FREAMINE III 8.5% W/ ELECTROLYTES is listed in Drugs@FDA under application 016822 (NDA).
Review priority: PRIORITY Marketing status: Discontinued Active ingredient AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE Form and strength INJECTABLE;INJECTION - 8.5%;110MG/100ML;230MG/100ML;10MG/100ML;440MG/100ML;690MG/100ML Sponsor B BRAUN Submission history Latest submission status date: 2014-03-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview FREAMINE III 8.5% W/ ELECTROLYTES is listed in Drugs@FDA under application 016822 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE Form and strength INJECTABLE;INJECTION - 8.5%;110MG/100ML;230MG/100ML;10MG/100ML;440MG/100ML;690MG/100ML Sponsor B BRAUN Submission history Latest submission status date: 2014-03-12 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.